Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancerUrsula Matulonis,Jorn Herrstedt,Amit Oza,Sven Mahner,Andres Redondo,Dominique Berton,Jonathan Berek,Bente Lund,Frederik Marme,Antonio Gonzalez-Martin,Anna Tinker,Jonathan Ledermann,Benedict Benigno,Gabriel Lindahl,Nicoletta Colombo,Yong Li,Divya Gupta,Bradley Monk,Mansoor MirzaGynecologic Oncology(2021)引用 38|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要